Loading the company…
Loading the company…
㈜리체바이오
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Daegu, founded in 2011. Industry: Wholesale & Retail. Revenue for 2025 was ₩15.5bn. It has 32 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2021-11-29 · newest first
본 발명은 기판; 상기 기판 상부에 위치하고, 케어받고자 하는 인체 부위에 대응되는 영역 내 일정 간격 이격되면서 배치되는 복수개의 듀얼 LED 칩부; 상기 기판 상부에 위치하고, 상기 듀얼 LED 칩부가 배치되지 않은 영역 내 일정 간격 이격되면서 배치되는 복수개의 원적외선 방출부; 및 상기 기판 하부에 위치하고, 상기 원적외선 방출부에 대응되도록 배치되는 열선부를 포함하되, 상기 듀얼 LED 칩부는 적색광 방출 LED 및 근적외선 방출 LED를 포함하는 것을 특징으로 하는, 기능성 좌욕장치에 관한 것이다.
본 발명은 폴리우레탄 필름층; 상기 폴리우레탄 필름층 하면에 적층된, 폴리우레탄 폼층; 및 상기 폴리우레탄 폼층 하면에 적층되고 그 하면이 상처면에 접촉하도록, 다공성 실리카 입자를 포함하는 기능성 폴리우레탄 폼층을 포함하는 창상피복재 및 이의 제조방법에 관한 것이다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 2 of 2 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 15.5 | 15.5 |
| Cost of sales | 9.3 | 8.6 |
| Gross profit (loss) | 6.2 | 6.8 |
| Selling, general and administrative expenses | 4.4 | 4.4 |
| Operating income (loss) | 1.8 | 2.4 |
| Non-operating income | 0.1 | 0.3 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.0 | 0.0 |
| Other | 0.0 | 0.3 |
| Non-operating expenses | 0.6 | 0.5 |
| Other losses | 0.0 | 0.0 |
| Finance costs | 0.6 | 0.5 |
| Other | 0.0 | — |
| Profit (loss) before tax | 1.3 | 2.3 |
| Income tax expense | 0.3 | 0.5 |
| Net income (loss) | 1.0 | 1.8 |
Revenue ₩15.5bn, down 0.2% YoY.
Operating margin 15.8% (prior 11.8%).
Net income ₩1.8bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.